PUBLICATIONS
Articles
MCDA in a hospital pharmacy and therapeutics committee
Multi-Criteria Decision Analysis as a Decision-support tool for Drug Evaluation: A Pilot Study in a Pharmacy and Therapeutics Comittee Setting. Avaliable at: https://www.cambridge.org/ [...]
Burden of Acromegaly
Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly Available at: https://jim.bmj.com/content/66/3/653.long [...]
Quality of life questionnaire in Acromegaly
Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly Avaliable at: https://www.tandfonline.com/doi/full/10.1080/13696998.2017.1419960 [...]
ACRODAT® software for Acromegaly
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly Available at: https://link.springer.com/article/10.1007/s11102-017-0835-5 [...]
MCDA framework in Catalonia for Orphan Drugs
Drug Evaluation and Decision Making in Catalonia: Development and Validation of a Methodological Framework Based on Multi-Criteria Decision Analysis (MCDA) for Orphan Drugs. Avaliable [...]
A New Article on MCDA Orphan Drug Assessment
Multicriteria Decision Analysis (MCDA) has been used to assess the evaluation of an orphan drug for the thyroid cancer treatment in Italy, Spain and France. Avaliable at: https://bmcca [...]